A BOLD statement on how to case-find moderate/severe COPD

European Respiratory Journal

Volumn 41, Issue 3, 2013, Pages 503-504

  Steenbruggen, Irene ^a   Zielinski, Jan ^b   Lange, Peter ^c,d   Price, David ^e,f   Soriano, Joan B ^g  

^a Pulmonary Laboratory   (Netherlands)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c HVIDOVRE HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f Research in Real Life Ltd   (United Kingdom)

^g Program of Epidemiology and Clinical Research CIMERA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASE FINDING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSENSUS DEVELOPMENT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; EDITORIAL; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; PATIENT CARE; PATIENT SELECTION; PEAK EXPIRATORY FLOW; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SENSITIVITY ANALYSIS; SMOKING; SPIROMETRY;

FEMALE; HUMANS; MALE; PEAK EXPIRATORY FLOW RATE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 84875243529     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00153512     Document Type: Editorial

References (13)

1. Bousquet J, Kiley J, Bateman ED, et al. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J 2010; 36: 995-1001.
2. Murray CJ, Lopez AD, Black R, et al. Global burden of disease 2005: Call for collaborators. Lancet 2007; 370: 109-110.
3. Institute for Health Metrics and Evaluation: Global Burden of Disease Study. www.globalburden.org/index.html Date last accessed: September 10, 2012.
4. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009; 374: 721-732.
5. Jithoo A, Enright PL, Burney P, et al. Case-finding options for COPD: Results from the Burden of Obstructive Lung Disease Study. Eur Respir J 2013; 41: 548-555.
6. Perez-Padilla R, Vollmer WM, Vázquez-García JC, et al. Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis 2009; 13: 387-393.
7. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: The global lung function 2012 equations. Eur Respir J 2012; 40: 1324-1343.
8. Frith P, CrockettA, Beilby J, et al. SimplifiedCOPDscreening: Validation of the PiKo-61 in primary care. Prim Care Respir J 2011; 20: 190-198.
9. Sichletidis L, Spyratos D, Papaioannou M, et al. A combination of the IPAG questionnaire and PiKo-61 flow meter is a valuable screening tool for COPD in the primary care setting. Prim Care Respir J 2011; 20: 184-189.
10. Zieliń ski J, Bednarek M, Know the Age of Your Lung Study Group. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001; 119: 731-736.
11. Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008; 63: 402-407.
12. Ulrik CS, Løkke A, Dahl R, et al. Early detection of COPD in general practice. Int J Chron Obstruct Pulmon Dis 2011; 6: 123-127.
13. Narodowy Fundusz Zdrowia (Polish Health Fund). http://nfz. gov.pl/new/index.php (website in Polish) Date last accessed: September 21, 2012.